CRIS Cancer Foundation

What CRIS Cancer Foundation does

CRIS Cancer Foundation is a UK-registered charity (Charity No. 1140193, Company No. 07493363) founded in 2011 and headquartered in South Kensington, London, that funds cutting-edge cancer research across adult and paediatric oncology. The foundation's core activities are channelled through research programmes covering adult cancer projects, paediatric cancer projects, cancer immunotherapy (including support for the Centre for Immunotherapy of Cancer at the Institute of Cancer Research in London), the Fight Kids Cancer European initiative, and a fellowship programme for early-career investigators.

The foundation does not develop proprietary technology; its product surface is a portfolio of grants, fellowships, and collaborative research programmes. It announced £12.6 million in research funding at CRIS Science Day 2026 across projects in the UK, Spain, and France. Research output is anchored by strategic partnerships with the Institute of Cancer Research (host of the Centre for Immunotherapy of Cancer) and the Royal Marsden Hospital for clinical translation, alongside a network of named international researchers.

Revenue is generated entirely through charitable giving: individual donations (one-time and monthly GEM membership), corporate partnerships (Charity of the Year, matching gifts, payroll giving), event-based fundraising (Royal Parks Half Marathon with £150 entry fee and £250 minimum fundraising commitment), and research fellowship funding. US donors are served through CAF America (a 501(c)(3)) for tax-efficient giving. The foundation operates with approximately 10 employees and an annual programme of donor engagement events including CRIS Science Day and the CRIS Research Insight Series.

Name

CRIS Cancer Foundation

Legal name

CRIS Cancer Foundation

Website

https://criscancer.org.uk

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

CRIS Cancer Foundation is a UK-registered charity founded in 2011 that funds adult and paediatric cancer research across the UK, Spain, and France, supporting grants, fellowships, and the Centre for Immunotherapy of Cancer via individual donations, corporate partnerships, and event-based fundraising.

Ownership category

akta.pro rank

Product category

Cancer Research Charity

NAICS

Voluntary Health Organizations (813212), Grantmaking Foundations (813211)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

• Cancer research funding
• Cancer immunotherapy research
• Paediatric cancer research
• Research fellowship programs
• Charity fundraising services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Infrastructure

Revenue model

1. Individual Donations: Direct donations from individuals, including one-time and recurring contributions. US taxpayers can donate through CAF America for tax efficiency.
2. Corporate Partnerships: Partnerships with companies including corporate donations, matching gifts, Charity of the Year programs, and event sponsorships.
3. Event-Based Fundraising: Fundraising through charity places in events like the Royal Parks Half Marathon, where runners commit to raising minimum amounts.
4. Research Fellowships: Funding for researchers including UK Fellows, CRIS-Prostate Cancer Foundation Fellows, and CRIS Cancer UK Fellows.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

CRIS Cancer Foundation is a registered UK charity that raises and deploys funds to support cutting-edge cancer research, including adult and paediatric cancer projects, immunotherapy programs, and research fellowships. The foundation channels donations, corporate partnerships, and event-based fundraising into research grants and fellowships at institutions such as the Institute of Cancer Research in London, with the goal of accelerating the translation of laboratory discoveries into patient treatments.

Product overview

CRIS Cancer Foundation operates as a cancer research charity, not a traditional product company. The organization functions as a funding and grants platform for cancer research, offering multiple interconnected research programs and fundraising services. Its core product portfolio includes: (1) Research Funding Programs - Adult Cancer Projects, Paediatric Cancer Projects, Cancer Immunotherapy research, and Fight Kids Cancer initiatives; (2) Fellowship Programs - CRIS Fellowships and the CRIS-Prostate Cancer Foundation Fellow; (3) Fundraising Services - Donation services (online/offline via CAF America), Royal Parks Half Marathon events, Corporate Partnership Programs, and the GEM monthly giving program. These services work together to advance the Foundation's mission of funding innovative cancer research and accelerating breakthroughs for patients worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Adult Cancer Projects

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core, flagship and supporting.

• Institute of Cancer Research (ICR)coreStrategic or Co-development PartnerHost of the Centre for Immunotherapy of Cancer (CIC), a leading initiative bringing together scientists and clinicians to advance cancer immunotherapy. CRIS funding has been instrumental in developing the CIC infrastructure and research platform.
• The Royal Marsden HospitalcoreStrategic or Co-development PartnerNHS foundation trust providing clinical integration with the Centre for Immunotherapy of Cancer at ICR, enabling translation of lab discoveries to clinical applications for patients.
• Prostate Cancer FoundationflagshipStrategic or Co-development PartnerJoint funding initiative resulting in the CRIS-Prostate Cancer Foundation Fellow, Dr Kathy Chung Ying Chan at ICR London, focused on innovative radiotherapy combined with immunotherapy for advanced prostate cancer.
• London Stock Exchange (LSE)flagshipStrategic or Co-development PartnerHonoured CRIS Cancer Foundation with a market closing ceremony on 9 June 2026 to mark 15 years of progress in cancer research, symbolizing organizational growth and partnership strength.
• Fight Kids CancerflagshipStrategic or Co-development PartnerEuropean childhood cancer research funding initiative. CRIS Cancer Foundation participates in this joint funding program to support paediatric cancer research across borders.
• Royal SocietysupportingStrategic or Co-development PartnerPrestigious UK scientific institution that hosted the CRIS Research Insight Series event in March 2026, providing venue for leading voices in cancer research.
• CAF AmericasupportingChannel Partner/ Reseller/ DistributorUS 501(c)(3) charity (tax ID 43-1634280) enabling American supporters to make tax-efficient donations to CRIS Cancer Foundation.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Cancer Research UK: The UK's largest cancer research charity, funding research across prevention, diagnosis, and treatment. Directly comparable to CRIS as a UK-based cancer research grantmaking organization, although operating at materially greater scale.
• Prostate Cancer Foundation: US-based foundation funding prostate cancer research worldwide, including the joint CRIS-PCF Fellowship. Directly comparable as a disease-specific cancer research grantmaker with international grant programs and corporate donor support.
• Children with Cancer UK: UK charity dedicated to funding paediatric cancer research, directly aligned with CRIS's Fight Kids Cancer and Paediatric Projects portfolio. Comparable donor base and grantmaking model focused on childhood malignancies.
• Macmillan Cancer Support: Major UK cancer charity providing clinical, financial, and emotional support alongside research funding. Comparable to CRIS as a UK cancer non-profit relying on donations, corporate partnerships, and community fundraising events.
• Worldwide Cancer Research: UK-headquartered charity funding cancer research projects globally. Comparable to CRIS in funding early-stage, investigator-led cancer research across multiple countries and operating primarily through donations.

Others

• AKO Foundation: UK-registered grantmaking foundation and corporate partner of CRIS. Comparable as a grantmaking entity distributing philanthropic capital, though not focused on cancer research.

Broad incumbents

• Stand Up To Cancer: Large-scale collaborative cancer research fundraising program. Comparable to CRIS in using high-profile campaigns and events to fund translational cancer research, though operating at significantly greater scale.
• The Institute of Cancer Research: Academic and research institution hosting the Centre for Immunotherapy of Cancer funded by CRIS. Comparable in cancer research focus but operates as a research performer rather than a grantmaking charity.
• Leukaemia & Lymphoma Society: US-based voluntary health organization funding blood cancer research, patient support, and policy. Comparable to CRIS as a disease-focused health charity funding investigator-led research and fellowships.

Regional players

• Pancreatic Cancer UK: UK-only disease-specific cancer charity funding research and supporting patients. Comparable to CRIS's disease-specific funding model but focused exclusively on pancreatic cancer and operating primarily within the UK.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cris-cancer-foundation

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CRIS Cancer Foundation